MD Anderson trials test psilocybin therapy for head and neck cancer patients and survivors, aiming to curb suicide risk and ease treatment trauma.
Moran Amit, MD, PhD
Advertisement
Moran Amit, MD, PhD, is a Surgeon-Scientist in the Department of Head and Neck Surgery and the Department of Genomic Medicine at MD Anderson Cancer Center, with faculty appointments in the UTHealth Graduate School of Biomedical Sciences
Articles by Moran Amit, MD, PhD
MD Anderson trial uses psilocybin-assisted therapy to help head and neck cancer patients cope with trauma and improve recovery.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Tentative Approval to New Cabozantinib Capsule Formulation
2
FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies
3
In Squamous NSCLC, Cemiplimab Data Pulled the Room Away From Dual Checkpoint Blockade
4
Real-World Analysis Explores GLP-1 Use and Overall Survival
5